Plaintiff
Defendant
- Parties: The plaintiffs were Boehringer Ingelheim (Canada) Ltd and Boehringer Ingelheim International GMBH. The defendant was Glenmark Pharmaceuticals Canada Inc.
- Subject Matter: This action concerned the Patented Medicines (NOC) Regulations.
- Date: The hearing was set on Mar. 14, 2024.
- Venue: This was a federal case before the Federal Court.
- Amount: No financial award was specified.
Court
Federal CourtCase Number
T-932-23Practice Area
Intellectual propertyAmount
Winner
Trial Start Date
02 May 2023Download documents